Search

Your search keyword '"Faure, Eva"' showing total 24 results
Start Over Author "Faure, Eva"
24 results on '"Faure, Eva"'

4. How to Strengthen Wildlife Surveillance to Support Freedom From Disease: Example of ASF Surveillance in France, at the Border With an Infected Area

Author

Desvaux, Stéphanie, primary, Urbaniak, Christophe, additional, Petit, Thibaut, additional, Chaigneau, Pauline, additional, Gerbier, Guillaume, additional, Decors, Anouk, additional, Reveillaud, Edouard, additional, Chollet, Jean-Yves, additional, Petit, Geoffrey, additional, Faure, Eva, additional, and Rossi, Sophie, additional

Published
2021
Full Text
View/download PDF

5. Characterization of New Molecular Markers of Three Botflies Parasitizing Cervid Hosts

Author

de la Fuente, Ana M, primary, Caparrós, Noelia, additional, Mora-Rodríguez, José M, additional, Molina, María, additional, Aleix-Mata, Gaël, additional, Velarde, Roser, additional, Fidalgo, Luis E, additional, López-Beceiro, Ana M, additional, Lorite, Pedro, additional, Boos, Mathieu, additional, Faure, Eva, additional, Pérez, Jesús M, additional, and Sánchez, Antonio, additional

Published
2021
Full Text
View/download PDF

8. Exposure of Wild Ungulates to the Usutu and Tick-Borne Encephalitis Viruses in France in 2009–2014: Evidence of Undetected Flavivirus Circulation a Decade Ago

Author

Bournez, Laure, primary, Umhang, Gérald, additional, Faure, Eva, additional, Boucher, Jean-Marc, additional, Boué, Franck, additional, Jourdain, Elsa, additional, Sarasa, Mathieu, additional, Llorente, Francisco, additional, Jiménez-Clavero, Miguel A., additional, Moutailler, Sara, additional, Lacour, Sandrine A., additional, Lecollinet, Sylvie, additional, and Beck, Cécile, additional

Published
2019
Full Text
View/download PDF

9. Red deer (Cervus elaphus) Did Not Play the Role of Maintenance Host for Bluetongue Virus in France: The Burden of Proof by Long-Term Wildlife Monitoring and Culicoides Snapshots

Author

Rossi, Sophie, primary, Balenghien, Thomas, additional, Viarouge, Cyril, additional, Faure, Eva, additional, Zanella, Gina, additional, Sailleau, Corinne, additional, Mathieu, Bruno, additional, Delécolle, Jean-Claude, additional, Ninio, Camille, additional, Garros, Claire, additional, Gardès, Laëtitia, additional, Tholoniat, Christophe, additional, Ariston, Agnès, additional, Gauthier, Dominique, additional, Mondoloni, Stevan, additional, Barboiron, Aurélie, additional, Pellerin, Maryline, additional, Gibert, Philippe, additional, Novella, Corinne, additional, Barbier, Stéphane, additional, Guillaumat, Etienne, additional, Zientara, Stéphan, additional, Vitour, Damien, additional, and Bréard, Emmanuel, additional

Published
2019
Full Text
View/download PDF

10. From epidemiological data to policy: revision of Bovine Tuberculosis control strategy in France for 2017-2022

Author

Cavalerie, Lisa, Chevalier, Fabrice, Jabert, Pierre, Véron, Louise, Réveillaud, Edouard, Girard, Sébastien, Moussu, Mikael, Anne-Laure Lefevre, Martin, Franck, Philizot, Stéphanie, Tourette, Isabelle, Faure, Eva, Desvaux, Stéphanie, Wiele, Anne Van De, Garin, Emmanuel, Keck, Nicolas, Durand, Benoît, Dufour, Barbara, Boschiroli, Maria Laura, Calavas, Didier, and Bronner, Anne

Published
2018
Full Text
View/download PDF

12. Host status of wild roe deer in bovine tuberculosis endemic areas

Author

Lambert, Sébastien, primary, Hars, Jean, additional, Réveillaud, Edouard, additional, Moyen, Jean-Louis, additional, Gares, Hélène, additional, Rambaud, Thomas, additional, Gueneau, Eric, additional, Faure, Eva, additional, Boschiroli, Maria-Laura, additional, and Richomme, Céline, additional

Published
2016
Full Text
View/download PDF

13. Pestes porcines : un point sur la surveillance de la PPA en 2014

Author

Amar, Philippe, Bourguignon, Patrick, Calavas, Didier, Charrier, François, Chollet, Jean-Yves, Clément, Thomas, Cornelis, Daniel, Decors, Anouk, Desvaux, Stephanie, Faure, Eva, Gallois, Mélanie, Garin, Emmanuel, Jori, Ferran, Le Coz, Philippe, Lepotier, Marie-Frédérique, Locatelli, Caroline, Poliak, Sylvie, Richomme, Céline, Rose, Nicolas, Rossi, Sophie, Tourette, Isabelle, Marcé, Clara, Coop de France, Société Nationale des Groupements Techniques Vétérinaires (SNGTV), Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail (ANSES), Laboratoire de Recherches sur le Développement de l'Elevage (LRDE), Institut National de la Recherche Agronomique (INRA), Office National de la Chasse et de la Faune Sauvage (ONCFS), SRAL, Centre de Coopération Internationale en Recherche Agronomique pour le Développement (Cirad), Direction Générale de l'Alimentation (DGAL), Fédération Nationale des Chasseurs (FNC), Fédération Régionale des Groupements de Défense Sanitaire de Corse, Partenaires INRAE, Association française des Directeurs et cadres de Laboratoires Vétérinaires publics d'Analyses (ADILVA), Groupement de Défense Sanitaire, and Bureau Santé Animale

Subjects
[SDV]Life Sciences [q-bio], ComputingMilieux_MISCELLANEOUS, [SHS]Humanities and Social Sciences
Abstract

National audience

Published
2015

16. Sex-specific disease outcomes of HIV-positive and HIV-negative drug users admitted to an opioid substitution therapy program in Spain : a cohort study

Author

Muga, Roberto, Rivas, Inmaculada, Faure, Eva, Fuster, Daniel, Zuluaga Cruz, Andrea Paola, Rubio, Manuela, Muñoz, Trinidad, Torrens, Marta, Tor, Jordi, Sanvisens, Arantza, and Universitat Autònoma de Barcelona

Subjects
Adult, Male, medicine.medical_specialty, Longitudinal study, Adolescent, Substance-Related Disorders, HIV Infections, Cohort Studies, Drug Users, Young Adult, Sex Factors, Acquired immunodeficiency syndrome (AIDS), Internal medicine, medicine, Opiate Substitution Treatment, Humans, Longitudinal Studies, Young adult, Mortality, Cause of death, Proportional Hazards Models, Opioid substitution treatment, Proportional hazards model, business.industry, Mortality rate, HIV, medicine.disease, Surgery, Hospitalization, Infectious Diseases, Spain, Female, business, Methadone, medicine.drug, Cohort study, Research Article
Abstract

Altres ajuts: We would like to thank the health care professionals working at CASDelta-Badalona, the mobile unit (Methadone Bus), and pharmaciesdispensing methadone in Badalona and Santa Coloma de Gramenet. This work has been made possible by the collaboration of the MortalityRegister, Institute of Health Studies, Department de Salut, Generalitat de Catalunya. Opioid substitution therapy has improved the survival of heroin users with and without HIV infection. We aimed to analyze sex differences in mortality rates and predictors of death among those admitted to a methadone treatment program (MTP). Longitudinal study of patients enrolled in a MTP from 1992 to 2010. Socio-demographic and drug use characteristics, and markers of viral infections were assessed at entry. Vital status was ascertained by clinical charts and the mortality register. Four calendar periods were defined according to the introduction of preventive and treatment interventions in Spain. Predictors of death were analyzed by Cox regression models. 1,678 patients (82.8% men) were included; age at first heroin use was 18.6 years (IQR: 16-23 years), and age at first entry into a MTP was 30.7 years (IQR: 26-36 years). A total of 441 (26.3%) deaths occurred during 15,124 person-years (p-y) of follow-up (median: 9.2 years, IQR: 4-13 years). HIV infection was the main predictor of death in men (HR = 3.5, 95% CI: 2.1-5.7) and women (HR = 3.2, 95% CI: 1.2-8.7) and main cause of death was HIV/AIDS. Overall mortality rate was 2.9 per 100 p-y (95% CI: 2.7-3.2 per 100 p-y) and death rates decreased over time: 7.4 per 100 p-y (95% CI: 6.3-8.8 per 100 p-y) for the 1992-1996 period to 1.9 per 100 p-y (95% CI: 1.6-2.4 per 100 p-y) for the 2007-2010 period. In women, a slightly increase in mortality was observed in recent periods specifically among HIV-positive women (3.7 per 100 p-y in period 2002-2006 and 4.5 per 100 p-y in 2007-2010). Significant reductions in mortality of patients in MTP are observed after nineteen years of observation. However, HIV infection shows a great impact on survival, particularly among HIV-infected women. The online version of this article (doi:10.1186/1471-2334-14-504) contains supplementary material, which is available to authorized users.

Published
2014

17. Projet VEILLE - Rapport intermédiaire Décembre 2014 [confidentiel]

Author

Jourdain, Elsa, Faure, Eva, Umhang, Gerald, Lecollinet, Sylvie, Sarasa, Mathieu, Unité de Recherche d'Épidémiologie Animale (UR EpiA), Institut National de la Recherche Agronomique (INRA), Fédération Nationale des Chasseurs (FNC), and Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail (ANSES)

Subjects
[SDV]Life Sciences [q-bio]
Published
2014

23. Exposure of Wild Ungulates to the Usutu and Tick-Borne Encephalitis Viruses in France in 2009–2014: Evidence of Undetected Flavivirus Circulation a Decade Ago.

Author

Bournez, Laure, Umhang, Gérald, Faure, Eva, Boucher, Jean-Marc, Boué, Franck, Jourdain, Elsa, Sarasa, Mathieu, Llorente, Francisco, Jiménez-Clavero, Miguel A., Moutailler, Sara, Lacour, Sandrine A., Lecollinet, Sylvie, and Beck, Cécile

Subjects
TICK-borne encephalitis viruses, FLAVIVIRUSES, JAPANESE encephalitis viruses, WEST Nile virus, UNGULATES, WILD boar, ROE deer
Abstract

Flaviviruses have become increasingly important pathogens in Europe over the past few decades. A better understanding of the spatiotemporal distribution of flaviviruses in France is needed to better define risk areas and to gain knowledge of the dynamics of virus transmission cycles. Serum samples from 1014 wild boar and 758 roe deer from 16 departments (administrative units) in France collected from 2009 to 2014 were screened for flavivirus antibodies using a competitive ELISA (cELISA) technique. Serum samples found to be positive or doubtful by cELISA were then tested for antibodies directed against West Nile virus (WNV), Usutu virus (USUV), Bagaza virus (BAGV), and tick-borne encephalitis/Louping ill viruses (TBEV/LIV) by microsphere immunoassays (except BAGV) and micro-neutralization tests. USUV antibodies were detected only in southeastern and southwestern areas. TBEV/LIV antibodies were detected in serum samples from eastern, southwestern and northern departments. The results indicate continuous circulation of USUV in southern France from 2009 to 2014, which was unnoticed by the French monitoring system for bird mortality. The findings also confirm wider distribution of TBEV in the eastern part of the country than of human clinical cases. However, further studies are needed to determine the tick-borne flavivirus responsible for the seroconversion in southwestern and northern France. [ABSTRACT FROM AUTHOR]

Published
2020
Full Text
View/download PDF

24. [Characteristics of heroin dependent patients admitted to a methadone treatment program].

Author

Sanvisens A, Rivas I, Faure E, Muñoz T, Rubio M, Fuster D, Tor J, and Muga R

Subjects
Adolescent, Adult, Comorbidity, Cross-Sectional Studies, Educational Status, Female, HIV Infections epidemiology, Hepatitis B, Chronic epidemiology, Hepatitis C, Chronic epidemiology, Heroin Dependence rehabilitation, Humans, Male, Mental Disorders epidemiology, Prevalence, Prisoners statistics & numerical data, Socioeconomic Factors, Spain epidemiology, Substance Abuse, Intravenous epidemiology, Substance Abuse, Intravenous rehabilitation, Urban Population, Young Adult, Heroin Dependence epidemiology, Methadone therapeutic use, Narcotic Antagonists therapeutic use, Opiate Substitution Treatment statistics & numerical data, Substance Abuse Treatment Centers statistics & numerical data
Abstract

Background and Objetive: Methadone is largely used as the primary opioid substitution therapy for the treatment of heroin addiction; the objective of the study was to describe the clinical characteristics of heroin abusers admitted into a methadone maintenance program (MMP) in metropolitan Barcelona., Method: Cross-sectional study in patients enrolled in MMP since its introduction in 1992 through December 2010. Socio-demographic data, drug use characteristics, prevalence of blood-borne infections (human immunodeficiency virus [HIV], and hepatitis B [HBV] and C [HCV]) and psychiatric co-morbidity were assessed at entry., Results: One thousand and six hundred seventy eight patients (82.8% male). A total of 608 (36.2%) patients were admitted during 1992-1996, 566 (33.7%) between 1997-2001, 305 (18.2%) between 2002-2006 and 199 (11.9%) in the last period. Age at admission to methadone increased significantly (28 years in period 1992-1996 vs. 37 years in the last period [P<.005]). The percentage of patients with a history of intravenous drug use decreased significantly (89.5% in first period vs. 56.4% in period 2007-2010 [P<.05]). Prevalence of HIV, HCV and HBV (HBcAb+) was 53.7, 73.6 and 61.3%, respectively. The prevalence of HIV decreased over time from 66.2% in first period to 43.5% in 2007-2010 (P<.05); the prevalence of HCV decreased significantly from 82.8% in 1992-1996 to 69.8% in last period (P<.05). Twenty five percent of patients had psychiatric co-morbidity at admission and the prevalence of psychiatric co-morbidity increased over time (21% in 1992-1996 and 32% in 2007-2010; P<.05)., Conclusion: Age at first opioid substitution therapy is increasing over time, as well as the proportion of patients with psychiatric co-morbidity. There were significant reductions in blood-borne infections., (Copyright © 2012 Elsevier España, S.L. All rights reserved.)

Published
2014
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results